203521-95-3

Usage

Uses

Used in Pharmaceutical Research:
N-Cbz-4-Methylisonipecotic acid ethyl ester is used as a precursor in the synthesis of various pharmaceuticals and bioactive molecules for [application reason] its ability to serve as a building block in organic synthesis, contributing to the creation of new drug candidates.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, N-Cbz-4-Methylisonipecotic acid ethyl ester is used as a key intermediate for [application reason] its potential to be incorporated into complex molecular structures, facilitating the discovery of novel therapeutic agents.
Used in Drug Discovery:
N-Cbz-4-Methylisonipecotic acid ethyl ester is utilized in drug discovery processes as a component in the development of new drugs and treatments for [application reason] its versatility in chemical reactions, allowing for the exploration of various chemical modifications to enhance pharmacological properties.
Used in Organic Synthesis:
In organic synthesis, N-Cbz-4-Methylisonipecotic acid ethyl ester is used as a reagent or starting material for [application reason] its functional groups that can be manipulated to form a wide array of chemical products, expanding the scope of synthetic chemistry.

InChI:InChI=1/C17H23NO4/c1-3-21-15(19)17(2)9-11-18(12-10-17)16(20)22-13-14-7-5-4-6-8-14/h4-8H,3,9-13H2,1-2H3

Upstream product

• 160809-38-1 1-benzyl 4-ethyl piperidine-1,4-dicarboxylate 
• 74-88-4 methyl iodide 
• 501-53-1 benzyl chloroformate 
• 1126-09-6 4-carbethoxypiperidine 

Relevant academic research and scientific papers

SPIRO AZETIDINE ISOXAZOLE DERIVATIVES AND THEIR USE AS SSTR5 ANTAGONISTS

Provided is a compound represented by the following formula (1) or a salt thereof, which has an SSTR5 antagonistic action: wherein each symbol has the same definition as in the specification.

1H-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors

Compounds of Formula (I) inhibit the PARP enzyme and are useful for treating a disease or a disorder associated with PARP. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I), methods of treatment comprising compounds of For

FUSED BENZENE DERIVATIVE AND USE

The present invention provides a compound represented by the general formula: [wherein Ring A represents an optionally substituted 5- to 8-membered ring, Ring B represents a further optionally substituted 4- to 10-membered ring, Ring C represents a further optionally substituted benzene ring, X1 represents carbon atom, X2 represents a carbon atom, an oxygen atom, etc., W represents a nitrogen atom, etc., Y11 represents a group represented by the formula CR2R3' (wherein R2 represents a hydrogen atom, a cyano group, a nitro group, etc., and R3' represents a hydrogen atom, a cyano group, a nitro group, etc., respectively), Y21 represents a group represented by the formula CR4R5' (wherein R4 represents a hydrogen atom, a cyano group, a nitro group, etc., and R5' represents a hydrogen atom, a cyano group, a nitro group, etc., respectively), etc., and R1 represents an electron-withdrawing group, respectively. The formula represents a single bond or a double bond] or a salt thereof, which is useful as an androgen receptor modulator.